Jules A Musing - Director, Therapeuticsmd, Inc

As of August 12, 2021


What is Jules A Musing's Net Worth?

The current estimated net worth of Therapeuticsmd, Inc's Director, Jules A Musing, is estimated to be about $150.77K . Jules A Musing owns about 5,000 units of Therapeuticsmd, Inc common stock. In the last 8 years at Therapeuticsmd, Inc, Jules A Musing has sold an estimated value of $100.92K worth.

What is Jules A Musing's Past Insider Trading?

Jules A Musing's largest purchase order was 6,318 units , worth over $13.58K on August 28, 2013. Jules A Musing's largest sale order was 17,400 units , worth over $100.92K on March 1, 2019. In total, Jules A Musing has made about 14 transactions over 8 years of their time at Therapeuticsmd, Inc. Jules A Musing usually trades in August and June, with the busiest year in 2013.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Jules A Musing's' Mailing Address?

  • Mailing address is 9 Innovation Way, Suite 100 Newark DE 19711 DE

Therapeuticsmd, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Robert G. Finizio 2020 $600,000 $1,524,751 - $600,000 $21,785 $2,746,536
Robert G. Finizio 2019 $600,000 - $2 $600,000 $22,218 $1,222,220
John C.K. Milligan, IV 2020 $450,000 $1,479,105 - $315,000 $31,285 $2,275,390
John C.K. Milligan, IV 2019 $450,000 - $645,956 $315,000 $29,683 $1,440,639
Edward Borkowski 2020 $430,000 - $3,599,967 $365,500 $81,687 $4,477,154
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/25743/000119312521116458/d152560ddef14a.htm

What are Therapeuticsmd, Inc's Past Insider Trades?

Therapeuticsmd, Inc's most recent insider trade came on December 2, 2021 by Michael C Donegan who sold 29,790 units worth $15.95K . In the last 8 years, insiders at Therapeuticsmd, Inc have sold an estimated value of $50.32M and bought an estimated value of $4.81M worth of shares. Insider trading is most common in March, with the busiest year in 2018. The most active traders at the company are John C.K. Milligan IV, Secretary/CEO subsidiary,  Robert G Finizio, CEO,  and Tommy G Thompson, Director .

TherapeuticsMD, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1